¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cont"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • contracture
  • contradeciduate placenta
    Å»¶ô¸·Èí¼öŹÝ
  • contraincision
    ´ëÃøÀý°³(´ëÃøÃ¼°³).
  • contraindicant
    ±Ý±âÁõÈÄ(Ð×Ðùñøý¦).
  • contraindication
    Åõ¾à±Ý±â, ¹èÇձݱâ.
  • contraindication
    ±Ý±â, ¹èÇձݱâ(ÛÕùêÐ×Ðû) ¡ì¾àÁ¦ÀÇ¡í.
  • contralateral
    ´ëÃøÀÇ, Å¸Ãø¼º, ¹Ý´ëÃø, ±³Â÷ÀûÀÎ.
  • contralateral antagonist
    ¹Ý´ëÃø±æÇ×±Ù
  • contralateral reflex
    (¹Ý)´ëÃø¼º(Óßö°àõÚãÞÒ).
  • contralateral sign
    (¹Ý)´ëÃø¼º ¡ÈÄ(¡­ó£ý¦).
  • contralateral synergist
    ¹Ý´ëÃøÇùµ¿±Ù, ¹Ý´ëÃø°øµ¿±Ù
  • contraparetic
    Áø°æÁ¦, °æ·Ã¾ïÁ¦Á¦, Áø°æÁ¦(òåÌâð¥)ÀÇ, °æ·Ã¾ïÁ¦ÀÇ.
  • contrariety =antagonism
    ±æÇ×(ÀÛ¿ë)(ÑÏù÷íÂéÄ), ±æÇ×(Çö»ó).
  • contraselection
    ¿ªµµÅÂ(ËçËÄ̬).
  • contrasexual
    ´ë¼º(Óßàõ)ÀÇ.
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
  • JrId: 25678
    JournalTitle: Contemporary therapy.
    MedAbbr: Contemp Ther
    ISSN: 0162-7244
    ESSN:
    IsoAbbr:
    NlmId: 7802331
  • JrId: 25745
    JournalTitle: Contemporary ob/gyn.
    MedAbbr: Contemp Ob Gyn
    ISSN: 0090-3159
    ESSN:
    IsoAbbr:
    NlmId: 367022
  • JrId: 25760
    JournalTitle: Contemporary drug problems.
    MedAbbr: Contemp Drug Probl
    ISSN: 0091-4509
    ESSN:
    IsoAbbr:
    NlmId: 323553
  • JrId: 25798
    JournalTitle: Contemporary psychoanalysis.
    MedAbbr: Contemp Psychoanal
    ISSN: 0010-7530
    ESSN:
    IsoAbbr:
    NlmId: 42624
  • JrId: 26407
    JournalTitle: Contemporary crises.
    MedAbbr: Contemp Crisis
    ISSN: 0378-1100
    ESSN:
    IsoAbbr:
    NlmId: 100972804
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • M24.5
    Contracture of joint
    °üÀýÀÇ ±¸Ãà
  • M62.4
    Contracture of muscle
    ±ÙÀ°ÀÇ ±¸Ãà
  • S30.1
    Contusion of abdominal wall
    º¹º®ÀÇ Å¸¹Ú»ó
  • S90.0
    Contusion of ankle
    ¹ß¸ñÀÇ Å¸¹Ú»ó
  • S20.0
    Contusion of breast
    À¯¹æÀÇ Å¸¹Ú»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
contrecoup injury of brain An injury occurring beneath the skull opposite to the area of impact.
(05 Mar 2000)
contrectation 1. Sexual foreplay prior to coition.
2. The impulse to caress or embrace one of the opposite sex.
Origin: L. Con-trecto, pp. -trectatus, to handle
(05 Mar 2000)
control In research, control subjects or control procedures permit comparison with experimental results. The first controlled clinical research was probably done in 1875 by the British naval surgeon James Lind who, on board the HMS Salisbury, gave sailors with scurvy either oranges or lemons or cider or vinegar or nutmeg (or another treatment) and after just six days discovered that the citrus-consuming sailors had recovered from scury, until then the scourge of extended sea voyages, while the sailors who had been given the other treatments remained uncured.
(12 Dec 1998)
control animal In research, an animal submitted to the same conditions as the others used for the experiment, but with the crucial factor (such as the injection of antitoxin, the administration of a drug, etc.) omitted.
See: control, control experiment.
(05 Mar 2000)
control arm The group of participants in a clinical trial who receive standard treatment or a placebo, against which those receiving the experimental treatment are compared.
(09 Oct 1997)
control element Generic term for a region of DNA, such as a promoter or enhancer adjacent to (or within) a gene that allows the regulation of gene expression by the binding of transcription factors.
(18 Nov 1997)
control experiment An experiment used to check another, to verify the result, or to demonstrate what would have occurred had the factor under study been omitted.
See: control, control animal.
(05 Mar 2000)
control gene See: operator gene, regulator gene.
(05 Mar 2000)
control group A group of subjects participating in the same experiment as another group of subjects, but which is not exposed to the variable under investigation.
See: experimental group.
(05 Mar 2000)
control limit A regulatory value applied to the airborne concentration in the workplace of a potentially poisonous substance which is judged to be reasonably practicable for the whole spectrum of work activities and which must not normally be exceeded.
(09 Oct 1997)
Control of Communicable Diseases in Man The internationally recognised authoritative manual now in the 15th (1990) edition, published by the American Public Health Association.
(05 Mar 2000)
control plot A plot in which no vegetation will be cut and natural succession will occur. A control plot serves as a baseline to compare other treatments (Early, Mid and Late Seral).
(05 Dec 1998)
control release suture Eyeless suture with thread attached to needle such that the two separate when tension is applied to the thread.
(05 Mar 2000)
control syringe A type of Luer-Lok syringe with thumb and finger rings attached to the proximal end of the barrel and to the tip of the plunger, allowing operation of the syringe with one hand.
Synonym: ring syringe.
(05 Mar 2000)
controlled clinical trial A clinical trial involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicine, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trial is characterised as a randomised controlled trial. However, trials employing treatment allocation methods such as coin flips, odd-even numbers, patient social security numbers, days of the week, medical record numbers, or other such pseudo- or quasi-random processes are simply designated as controlled clinical trials.
(12 Dec 1998)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
contrast color an illusory tinge of complementary hue or brightness induced by a vivid hue or luminance on the area surrounding it in the visual field.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
contusion cataract one due to shock or to injury of the eyeball.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
controlled area In telecommunication, the term controlled area is an area in which uncontrolled movement will not result in compromise of classified information, that is designed to provide administrative control and safety, or that serves as a buffer for controlling access to limited-access areas. ...
Ãâó: en.wikipedia.org/wiki/Controlled_area
contour The Comet Nucleus Tour (CONTOUR) was a Discovery-class space mission. It had as its primary objective close fly-bys of two comet nuclei with the possibility of a fly-by of a third known comet or an as-yet-undiscovered comet. The two comets scheduled to be visited were Encke and Schwassmann-Wachmann-3, and the third target was d'Arrest. ...
Ãâó: en.wikipedia.org/wiki/CONTOUR
continuous spectrum In mathematics and physics, continuous spectrum is, roughly speaking, a non-countable set of eigenvalues of an operator. An operator acting on a Hilbert space is said to have a continuous spectrum if its eigenvalues can be changed continuously. If the spectrum of an operator is not continuous, we say that it is has discrete spectrum. ...
Ãâó: en.wikipedia.org/wiki/Continuous_spectrum
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • continuation
    Áö¼Ó
  • continuation
    °è¼ÓµÊ;°è¼Ó;¿¬¼Ó;(Áß´ÜÈÄ)°è¼Ó;Àç°³;(À̾߱âµîÀÇ)°è¼Ó;½ÂÀü;¼ÓÆí(sequel);°è¼ÓµÊ;Áö¼Ó;Á¸¼Ó(continuance);¿¬Àå;(prolongation);ÁõÃà;(°á»êÀÇ)ÀÌ¿¬;ÀÌ¿ù°Å·¡;ªÀº ¹ÙÁöÀÇ ¹«¸­ ÀÌÇÏÀÇ ºÎºÐ;¹ÙÁö(trousers)
  • continuation day
    =CONTANGO DAY
  • continuation rate
    ÀÌ¿ù ÀϺ¯
  • continuation school
    (±Ù·Î û¼Ò³âÀ» À§ÇÑ)º¸½ÀÇб³
  • continuative
    ¿¬¼ÓÀûÀÎ;°è¼ÓÀûÀÎ;¿¬´ÞÀº;¿¬¼ÓÇÏ´Â °Í;°è¼Ó»ç(°ü°è´ë¸í»ç.Á¢¼Ó»ç.ÀüÄ¡»ç µî)
  • continuator
    °è¼ÓÀÚ;Àΰè¹ÞÀº »ç¶÷;°è½ÂÀÚ
  • continue
    Áö¼ÓÇÏ´Ù,°è¼ÓÇÏ´Ù
  • continue
    ¿¡)°è¼ÓÇÏ¿© Áø¼úÇÏ´Ù;ÆäÀÌÁö·Î(¿¡¼­) °è¼Ó;°è¼Ó(Á¸¼Ó)½ÃŰ´Ù;¿¬ÀåÇÏ´Ù;¿¬±âÇÏ´Ù;ÀÌ¿ùÇÏ´Ù;ÀÌ¿¬ÇÏ´Ù;°è¼ÓµÇ´Ù;°Ô¼ÓÇϰí ÀÖ´Ù(go on);Á¸¼ÓÇÏ´Ù;°è¼ÓÇÏ´Ù(last);¸Ó¹«¸£´Ù(a °è¼ÓÇÏ´Ù,Áö¼ÓÇÏ´Ù,(opp.stop);(ÀÏ´Ü Áß´ÜÇß´Ù°¡´Ù½Ã)°è¼ÓÇÏ´Ù;(t,in);(º¸¾î¿Í ÇÔ²²)°è¼Ó...ÀÌ´Ù;~uer;
  • continued bond
    »óȯ¿¬±â°øÃ¤(ȸ»çä)
  • continued fraction
    ¿¬ºÐ¼ö
  • continued proportion
    ¿¬ºñ·Ê
  • continued story
    ¿¬Àç¼Ò¼³(serial)
  • continuing
    ¿¬¼ÓÀûÀÎ;°è¼ÓÀûÀÎ;°»½ÅÇÒ Çʿ䰡 ¾ø´Â;¿µ±¸ÀûÀÎ
  • continuing education
    °è¼Ó ±³À°;¼ºÀÎ ±³À°(ÃֽŠÁö½Ä.±â´ÉÀ» °¡¸£Ä¡´Â)
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 12
cont to make the subject of dispute, contention, or litigation
cont capable of being contested
cont a person who participates in competitions
cont a person who dissents from some established policy
cont a contentious speech act
cont disputed or made the object of contention or competition
cont a winner (of a race or an election etc.) whose victory is contested
cont someone who contests an outcome (of a race or an election etc.)
cont discourse that surrounds a language unit and helps to determine its interpretation
cont the set of facts or circumstances that surround a situation or event
cont discourse that surrounds a language unit and helps to determine its interpretation
cont relating to or determined by or in context
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 12
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á